We report a new non-invasive measure of lung oxygenation function (S/F94), evaluate it using physiological modelling data, and quantify the improvement in statistical power from using S/F94 in a clinical trial. We created a completely synthetic dataset that retains the properties of our >300,000 patient ISARIC4C cohort, and built a trial outcomes assessment tool.